Detalhe da pesquisa
1.
Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.
Value Health
; 26(1): 71-80, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973926
2.
Whole genome sequencing in oncology: using scenario drafting to explore future developments.
BMC Cancer
; 21(1): 488, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933021
3.
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.
J Med Econ
; 27(1): 445-454, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436289
4.
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.
Pharmacoeconomics
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771521
5.
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.
Pharmacoeconomics
; 42(4): 419-434, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194023
6.
Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study.
Adv Ther
; 40(12): 5399-5414, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803205
7.
Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients.
Pharmacoeconomics
; 41(10): 1263-1274, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318748
8.
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.
Sci Rep
; 13(1): 2349, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759641
9.
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
Pharmacoeconomics
; 39(12): 1429-1442, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405371